vs

Side-by-side financial comparison of biote Corp. (BTMD) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.

InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $46.4M, roughly 1.7× biote Corp.). biote Corp. runs the higher net margin — 4.2% vs 3.4%, a 0.8% gap on every dollar of revenue. On growth, InvenTrust Properties Corp. posted the faster year-over-year revenue change (8.6% vs -6.9%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $6.5M). Over the past eight quarters, InvenTrust Properties Corp.'s revenue compounded faster (7.6% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.

BTMD vs IVT — Head-to-Head

Bigger by revenue
IVT
IVT
1.7× larger
IVT
$77.4M
$46.4M
BTMD
Growing faster (revenue YoY)
IVT
IVT
+15.5% gap
IVT
8.6%
-6.9%
BTMD
Higher net margin
BTMD
BTMD
0.8% more per $
BTMD
4.2%
3.4%
IVT
More free cash flow
IVT
IVT
$104.4M more FCF
IVT
$110.9M
$6.5M
BTMD
Faster 2-yr revenue CAGR
IVT
IVT
Annualised
IVT
7.6%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
IVT
IVT
Revenue
$46.4M
$77.4M
Net Profit
$2.0M
$2.7M
Gross Margin
Operating Margin
14.7%
-11.0%
Net Margin
4.2%
3.4%
Revenue YoY
-6.9%
8.6%
Net Profit YoY
-47.2%
-72.8%
EPS (diluted)
$0.05
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
IVT
IVT
Q4 25
$46.4M
$77.4M
Q3 25
$48.0M
$74.5M
Q2 25
$48.9M
$73.6M
Q1 25
$49.0M
$73.8M
Q4 24
$49.8M
$71.2M
Q3 24
$51.4M
$68.5M
Q2 24
$49.2M
$67.4M
Q1 24
$46.8M
$66.8M
Net Profit
BTMD
BTMD
IVT
IVT
Q4 25
$2.0M
$2.7M
Q3 25
$8.2M
$6.0M
Q2 25
$3.2M
$95.9M
Q1 25
$13.7M
$6.8M
Q4 24
$3.7M
$9.8M
Q3 24
$10.7M
$-539.0K
Q2 24
$-7.1M
$1.5M
Q1 24
$-4.2M
$2.9M
Operating Margin
BTMD
BTMD
IVT
IVT
Q4 25
14.7%
-11.0%
Q3 25
17.2%
-9.8%
Q2 25
22.0%
Q1 25
19.8%
-10.5%
Q4 24
5.6%
-3.6%
Q3 24
23.7%
-18.7%
Q2 24
12.7%
-13.6%
Q1 24
22.3%
-13.1%
Net Margin
BTMD
BTMD
IVT
IVT
Q4 25
4.2%
3.4%
Q3 25
17.1%
8.1%
Q2 25
6.5%
130.4%
Q1 25
28.0%
9.2%
Q4 24
7.4%
13.8%
Q3 24
20.8%
-0.8%
Q2 24
-14.4%
2.2%
Q1 24
-8.9%
4.3%
EPS (diluted)
BTMD
BTMD
IVT
IVT
Q4 25
$0.05
$0.02
Q3 25
$0.22
$0.08
Q2 25
$0.10
$1.23
Q1 25
$0.37
$0.09
Q4 24
$0.09
$0.14
Q3 24
$0.33
$-0.01
Q2 24
$-0.21
$0.02
Q1 24
$-0.12
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
IVT
IVT
Cash + ST InvestmentsLiquidity on hand
$24.1M
Total DebtLower is stronger
$103.1M
$825.9M
Stockholders' EquityBook value
$-58.5M
$1.8B
Total Assets
$107.6M
$2.8B
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
IVT
IVT
Q4 25
$24.1M
Q3 25
$28.0M
Q2 25
$19.6M
Q1 25
$41.7M
Q4 24
$39.3M
Q3 24
$38.2M
Q2 24
$26.4M
Q1 24
$78.8M
Total Debt
BTMD
BTMD
IVT
IVT
Q4 25
$103.1M
$825.9M
Q3 25
$104.7M
$764.6M
Q2 25
$106.3M
$746.3M
Q1 25
$107.8M
$740.7M
Q4 24
$109.4M
$740.4M
Q3 24
$110.9M
$740.1M
Q2 24
$112.5M
$812.2M
Q1 24
$114.1M
$827.5M
Stockholders' Equity
BTMD
BTMD
IVT
IVT
Q4 25
$-58.5M
$1.8B
Q3 25
$-72.8M
$1.8B
Q2 25
$-85.1M
$1.8B
Q1 25
$-90.0M
$1.7B
Q4 24
$-105.9M
$1.8B
Q3 24
$-130.3M
$1.8B
Q2 24
$-143.2M
$1.5B
Q1 24
$-36.0M
$1.5B
Total Assets
BTMD
BTMD
IVT
IVT
Q4 25
$107.6M
$2.8B
Q3 25
$111.3M
$2.7B
Q2 25
$104.8M
$2.7B
Q1 25
$123.4M
$2.6B
Q4 24
$122.4M
$2.6B
Q3 24
$101.3M
$2.6B
Q2 24
$92.9M
$2.5B
Q1 24
$160.1M
$2.5B
Debt / Equity
BTMD
BTMD
IVT
IVT
Q4 25
0.46×
Q3 25
0.42×
Q2 25
0.41×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.53×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
IVT
IVT
Operating Cash FlowLast quarter
$7.6M
$155.4M
Free Cash FlowOCF − Capex
$6.5M
$110.9M
FCF MarginFCF / Revenue
14.0%
143.3%
Capex IntensityCapex / Revenue
2.3%
57.5%
Cash ConversionOCF / Net Profit
3.87×
58.41×
TTM Free Cash FlowTrailing 4 quarters
$30.2M
$193.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
IVT
IVT
Q4 25
$7.6M
$155.4M
Q3 25
$14.1M
$43.8M
Q2 25
$7.1M
$48.7M
Q1 25
$6.5M
$20.2M
Q4 24
$12.4M
$136.9M
Q3 24
$15.6M
$38.4M
Q2 24
$9.9M
$46.7M
Q1 24
$7.4M
$14.8M
Free Cash Flow
BTMD
BTMD
IVT
IVT
Q4 25
$6.5M
$110.9M
Q3 25
$13.6M
$31.4M
Q2 25
$5.3M
$38.0M
Q1 25
$4.8M
$12.8M
Q4 24
$10.7M
$100.8M
Q3 24
$14.0M
$29.3M
Q2 24
$7.4M
$37.2M
Q1 24
$6.7M
$7.7M
FCF Margin
BTMD
BTMD
IVT
IVT
Q4 25
14.0%
143.3%
Q3 25
28.3%
42.2%
Q2 25
10.8%
51.6%
Q1 25
9.9%
17.4%
Q4 24
21.5%
141.5%
Q3 24
27.3%
42.8%
Q2 24
15.1%
55.2%
Q1 24
14.2%
11.5%
Capex Intensity
BTMD
BTMD
IVT
IVT
Q4 25
2.3%
57.5%
Q3 25
1.0%
16.7%
Q2 25
3.7%
14.6%
Q1 25
3.3%
10.0%
Q4 24
3.4%
50.7%
Q3 24
3.0%
13.3%
Q2 24
5.1%
14.0%
Q1 24
1.5%
10.6%
Cash Conversion
BTMD
BTMD
IVT
IVT
Q4 25
3.87×
58.41×
Q3 25
1.72×
7.27×
Q2 25
2.22×
0.51×
Q1 25
0.47×
2.97×
Q4 24
3.34×
13.97×
Q3 24
1.45×
Q2 24
31.15×
Q1 24
5.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

IVT
IVT

Segment breakdown not available.

Related Comparisons